Skip to main content
. 2023 Feb 9;11:100167. doi: 10.1016/j.lansea.2023.100167

Table 2.

Laboratory findings in COVID-19 patients.

Variable Total (n = 689) Died (n = 103) Discharged alive (n = 586) p-value
Hemoglobin, g/dL (n = 668) 13.8 (12.5–15.0) 13.9 (12.7–15.3) 13.7 (12.5–14.9) 0.203
Anemia
 Yes 432 (100) 69 (16.0) 363 (84.0) 0.257
 No 236 (100) 30 (12.7) 206 (87.3)
Hematocrit, % (n = 667) 40.0 (36.4–43.2) 40.1 (36.3–44.1) 40.0 (36.4–43.2) 0.509
WBC count, × 109 per L (n = 667) 7.9 (5.9–10.8) 9.4 (6.6–14.0) 7.7 (5.8–10.4) 0.001∗
 <4 34 (100) 4 (11.8) 30 (88.2) 0.004∗
 4–10 431 (100) 53 (11.8) 378 (88.2)
 >10 202 (100) 46 (21.8) 156 (78.2)
Neutrophil, % (n = 659) 74.0 (63.0–82.0) 83.0 (76.0–87.0) 72.0 (61.0–81.0) <0.001∗
Lymphocyte, % (n = 659) 18.0 (11.0–27.0) 10.5 (7.0–16.3) 19.0 (12.0–29.0) <0.001∗
Absolute lymphocyte count (n = 659) 1360 (948–1890) 996 (690–1424) 1440 (1010–1931) <0.001∗
Neutrophil lymphocyte count ratio (n = 659) 4.2 (2.3–7.4) 7.7 (4.7–12.8) 3.8 (2.2–6.5) <0.001∗
 >3.53 384 (100) 86 (22.4) 298 (77.6) <0.001∗
 ≤3.53 275 (100) 12 (4.4) 263 (95.5)
Platelet count, × 109 per L (n = 6 63) 265 (208–326) 242 (170–324) 267 (216–327) 0.028∗
C-reactive protein, mg/L (n = 506) 3.5 (0.6–9.8) 12.3 (6.9–18.2) 2.8 (0.5–8.8) <0.001∗
 ≥100 122 (100) 32 (26.2) 90 (73.8) <0.001∗
 <100 384 (100) 23 (6.0) 361 (94.0)
Albumin, g/L (n = 436) 2.9 (2.4–3.7) 2.3 (2.2–2.6) 3.1 (2.5–3.7) <0.001∗
 <3.5 303 (100) 53 (17.4) 251 (82.8) <0.001∗
 ≥3.5 133 (100) 1 (1.9) 131 (98.5)
D-dimer, mcg/L (n = 492) 0.8 (0.4–2.0) 1.9 (1.0–4.8) 0.8 (0.4–1.8) <0.001∗
 >1000 211 (100) 39 (18.5) 172 (81.5) <0.001∗
 >500–1000 126 (100) 7 (5.6) 119 (94.4)
 ≤500 156 (100) 3 (1.9) 153 (98.1)
Procalcitonin, ng/mL (n = 4 66) 0.05 (0.01–0.20) 0.38 (0.16–1.21) 0.05 (0.01–0.15) <0.001∗
 ≥0.5 67 (100) 23 (34.3) 44 (65.7) <0.001∗
 <0.5 399 (100) 27 (6.8) 372 (93.2)

COVID-19, coronavirus disease 2019; WBC, white blood cell count; ∗, statistically significant (p-value <0.05).